SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-324492
Filing Date
2021-11-09
Accepted
2021-11-09 16:19:28
Documents
100
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q d211807d10q.htm   iXBRL 10-Q 1678430
2 EX-31.1 d211807dex311.htm EX-31.1 7346
3 EX-31.2 d211807dex312.htm EX-31.2 7337
4 EX-32.1 d211807dex321.htm EX-32.1 4913
  Complete submission text file 0001193125-21-324492.txt   8704584

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA orgo-20210930.xsd EX-101.SCH 71689
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orgo-20210930_cal.xml EX-101.CAL 61371
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orgo-20210930_def.xml EX-101.DEF 398902
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20210930_lab.xml EX-101.LAB 545483
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20210930_pre.xml EX-101.PRE 516315
10 EXTRACTED XBRL INSTANCE DOCUMENT d211807d10q_htm.xml XML 1492757
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37906 | Film No.: 211392489
SIC: 2834 Pharmaceutical Preparations